companydata.dkcompanydata.dk

PharmaSphere Consulting ApS: Financial statements 2024

CVR: 36696222

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

PharmaSphere Consulting ApS (CVR 36696222) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,629,520 and a net result of DKK 688,490 compared with DKK 319,633 the year before. That is an increase of 56.5% compared with the year before. Equity in the 2024 report amounted to DKK 744,961. The solvency ratio was 54%. The company had 1 employee in the financial year.

Gross Profit
DKK 2,629,520
Profit/Loss
DKK 688,490
Equity
DKK 744,961
Total Assets
DKK 1,378,460
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-2.6 mio.688 t.745 t.1
2023-1.7 mio.320 t.386 t.1
2022-916 t.266 t.317 t.1
2021-138 t.88 t.138 t.1
2020-294 t.25 t.75 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

PharmaSphere Consulting ApS: The 2023 annual report is outMar 1, 2024

PharmaSphere Consulting ApS has published its annual report for 2023. Gross profit came to DKK 1,680,379, and the net result was DKK 319,633.

About PharmaSphere Consulting ApS

PharmaSphere Consulting ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2015. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Søren Graves Truelsen. The company is owned by STruelsen-Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,479,823 and a net result of DKK 321,621 compared with DKK 688,490 the year before. Equity in the 2025 report amounted to DKK 466,582.

Source: annual report 2025, Danish Business Authority